A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine

The BCG vaccine has long been recognized for reducing the risk to suffer from infectious diseases unrelated to its target disease, tuberculosis. Evidence from human trials demonstrate substantial reductions in all-cause mortality, especially in the first week of life. Observational studies have iden...

Full description

Bibliographic Details
Main Authors: Amenyogbe, N. (Author), Ben-Othman, R. (Author), Brook, B. (Author), Kollmann, T. (Author), Schaltz-Buchholzer, F. (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2022
Subjects:
BCG
Online Access:View Fulltext in Publisher